Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gene expression markers for predicting overall survival in subjects treated with sipuleucel-T

Gene expression markers for predicting overall survival in subjects treated with sipuleucel-T

US Patent 11970743 · Granted Apr 30, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD19-directed chimeric antigen receptors and uses thereof in immunotherapy2025
Immune cells comprising truncated NKG2D chimeric receptors2025
Genetically modified natural killer cells for CD70-directed cancer immunotherapy2024
Anti-VEGF-PD1 bispecific antibody with novel structure and use thereof2023
Truncated NKG2D chimeric receptors and uses thereof in natural killer cell immun2022
CD19-directed chimeric antigen receptors and uses thereof in immunotherapy2022
Cancer immunotherapy using CD19-directed chimeric antigen receptors2021
Immune cells engineered to express CD19-directed chimeric antigen receptors and 2021
Predictive modeling across multiple horizons combining time series and external 2020
Humoral immune response against tumor antigens after treatment with a cancer ant2019
Humoral immune response against tumor antigens after treatment with a cancer ant2019
Humoral immune response against tumor antigens after treatment with a cancer ant2019